Nova Southeastern University
Robert H. Getzenberg, Ph.D. is currently the Executive Associate Dean for Research and Professor of Medicine at the Dr. Kiran C. Patel College of Allopathic Medicine at the Nova Southeastern University. In this position he directs the research of the College and fosters novel programs and interactions. Prior to joining Nova Southeastern his was the Chief Scientific Officer at Veru Pharma Inc. He previously served as the Therapeutic Area Lead, Prostate Cancer at GTx Inc. Prior to these positions he was the Director of Research of the James Buchanan Brady Urological Institute and the Donald S. Coffey Professor of Urology and Professor of Pharmacology and Molecular Sciences at the Johns Hopkins University School of Medicine.
Dr. Getzenberg received his Ph.D. from the Johns Hopkins University School of Medicine in 1992 under the tutelage of Dr. Donald S. Coffey. He then completed a post-doctoral fellowship at the Yale University School of Medicine. After completing his fellowship, Dr. Getzenberg joined the University of Pittsburgh as an Assistant Professor but eventually was named the Director of Urology Research and a Professor of Urology, Pathology and Pharmacology.
Dr. Getzenberg is the recipient of a number of awards including the 2000 University of Pittsburgh Chancellor’s Distinguished Research Award and was selected as one of the “40 under 40” by Pittsburgh Magazine. He is the recipient of a number of grants from the NIH and other agencies and foundations. Dr. Getzenberg has given numerous international lectures including the first Donald Gleason Lecture at the University of Minnesota and the Weisbach Lecture at the University of Michigan. Dr. Getzenberg has and continues to serve in many leadership positions in urology research. He served as Treasurer and President of the Society of Basic Urologic Research and in many research capacities at the American Urological Association.